Inflammation, Inflammaging, and the Biology of Aging

Inflammation is not inherently harmful. Acute inflammation, the localized, short-duration immune response to injury or infection, is essential for survival. It eliminates pathogens, clears damaged tissue, and initiates repair. The problem is when inflammation becomes chronic: a sustained, low-grade, systemic process that no longer serves an acute defensive purpose and instead contributes progressively to tissue damage and disease.

Claudio Franceschi and colleagues coined the term 'inflammaging' in the early 2000s to describe this phenomenon: the smoldering, low-level chronic inflammatory state that characterizes aging and that is associated with the development of virtually every major age-related disease, including cardiovascular disease, type 2 diabetes, neurodegenerative conditions, and many cancers.

What Is Inflammaging?

Inflammaging is not the acute inflammation you experience after a cut or infection. It is subclinical, often present without obvious symptoms and best measured through biomarkers such as high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and other pro-inflammatory cytokines that circulate at elevated levels in aging tissues.

The 2023 update to the hallmarks of aging framework formally included chronic inflammation as a standalone hallmark, reflecting the accumulated weight of evidence. Population studies consistently find that individuals with higher circulating inflammatory markers in middle age have significantly elevated risk of disability, cognitive decline, and mortality over subsequent decades, independent of traditional cardiovascular risk factors.

Biological Drivers of Chronic Inflammation

Multiple hallmarks of aging contribute to inflammaging. Cellular senescence is a major driver: senescent cells secrete a complex mixture of pro-inflammatory cytokines, chemokines, growth factors, and proteases collectively called the senescence-associated secretory phenotype (SASP). As senescent cell burden accumulates with age, the SASP creates an increasingly inflammatory tissue environment.

Mitochondrial dysfunction contributes to inflammaging through mitochondrial stress responses and the release of mitochondrial DNA into the cytoplasm, where it activates innate immune sensors (the cGAS-STING pathway) that initiate inflammatory signaling. Gut dysbiosis, age-related changes in the microbiome, increases intestinal permeability, allowing bacterial products (particularly lipopolysaccharide, or LPS) to translocate into circulation, where they activate systemic inflammatory responses.

Accumulation of oxidative damage, declining autophagy, and epigenetic changes that alter expression of inflammatory regulatory genes all contribute to the progressive shift toward chronic inflammatory states over time. The master transcriptional regulator of inflammation, NF-κB, shows increasing baseline activity in aging tissues, creating a sustained pro-inflammatory set point.

Genetics and Individual Inflammatory Tendency

Genetic variation significantly influences baseline inflammatory tendency. Variants in genes encoding inflammatory cytokines (IL-6, TNF-α, IL-1β), their receptors, and regulatory pathways can predispose individuals to higher or lower inflammatory responses to the same stimulus. Common variants in the CRP gene influence baseline CRP levels. The APOE4 allele is associated with higher baseline inflammatory signaling and is one of the strongest genetic predictors of both cardiovascular and Alzheimer's disease risk.

Variants in NF-κB pathway components, antioxidant enzyme genes (SOD2, GPX), and cytokine regulatory networks contribute to inter-individual variation in inflammatory aging trajectory. Someone with genetic variants favoring higher inflammatory responses may benefit more from anti-inflammatory lifestyle strategies and targeted nutritional support than someone with a lower-inflammation genetic profile.

Consequences of Chronic Inflammation

Chronic low-grade inflammation creates damage through multiple mechanisms. It contributes to endothelial dysfunction and arterial stiffness, key drivers of cardiovascular disease risk. It impairs insulin signaling, contributing to insulin resistance and eventually type 2 diabetes. It promotes adipose tissue dysfunction and visceral fat accumulation, which further amplifies inflammatory signaling in a positive feedback cycle.

In the brain, chronic neuroinflammation, driven partly by systemic inflammaging signals crossing the blood-brain barrier and partly by local microglial activation, is increasingly recognized as central to neurodegenerative disease progression. In muscle, inflammatory cytokines promote muscle protein breakdown and impair anabolic signaling, contributing to sarcopenia (age-related muscle loss). In bone, inflammatory signals promote osteoclast activity, contributing to bone density loss.

Modulating Inflammaging Through Lifestyle and Nutrition

While no single intervention eliminates inflammaging, multiple lifestyle and nutritional strategies have meaningful, evidence-supported effects on inflammatory biomarkers and downstream outcomes. Regular moderate-intensity exercise reduces circulating inflammatory cytokines, likely through multiple mechanisms including improved metabolic health, reduced adipose tissue, and direct muscle-derived anti-inflammatory signals (myokines released during contraction).

Dietary patterns strongly influence inflammatory status. Mediterranean-style eating patterns, high in olive oil, fish, vegetables, legumes, and polyphenol-rich plant foods, are among the most consistently anti-inflammatory dietary patterns in human research. Omega-3 fatty acids (EPA and DHA) compete with pro-inflammatory arachidonic acid for conversion by COX and LOX enzymes, reducing the balance toward resolution-promoting lipid mediators. Specific polyphenols, curcumin, resveratrol, quercetin, have demonstrated anti-inflammatory activity in cell and animal studies, with more variable evidence in human trials.

Adequate sleep and effective management of psychological stress both influence inflammatory signaling through hypothalamic-pituitary-adrenal axis and autonomic nervous system pathways. A healthy gut microbiome reduces LPS translocation and supports the production of short-chain fatty acids with anti-inflammatory properties. Managing adiposity, particularly visceral fat, significantly reduces inflammatory cytokine secretion from adipose tissue.

Key Takeaways

Inflammaging is chronic low-grade systemic inflammation associated with aging and linked to virtually all major age-related diseases. It is now a formal hallmark of aging. Drivers include senescent cells, mitochondrial dysfunction, gut dysbiosis, oxidative damage, and NF-κB activation. Genetic variation influences individual baseline inflammatory tendency. Consequences span cardiovascular disease, insulin resistance, neurodegeneration, sarcopenia, and bone loss. Key modulators include exercise, anti-inflammatory dietary patterns, omega-3s, polyphenols, sleep, stress management, gut health, and body composition optimization.